Neue Therapiestrategien beim primären Lymphom des Zentralnervensystems
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neue Therapiestrategien beim primären Lymphom des Zentralnervensystems
Authors
Keywords
-
Journal
NERVENARZT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-01
DOI
10.1007/s00115-023-01561-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma
- (2023) Christian Grommes et al. LEUKEMIA & LYMPHOMA
- Primary central nervous system lymphoma
- (2023) Andrés J. M. Ferreri et al. Nature Reviews Disease Primers
- Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas
- (2023) Leon D. Kaulen et al. ACTA NEUROPATHOLOGICA
- Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
- (2022) Matthew J. Frigault et al. BLOOD
- Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
- (2022) Philipp Karschnia et al. NEUROLOGY
- The genomic and transcriptional landscape of primary central nervous system lymphoma
- (2022) Josefine Radke et al. Nature Communications
- Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon
- (2022) Massimo Martino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Toxicity and Efficacy of CAR T-cell Therapy in PCNSL and SCNSL: A Meta-Analysis of 128 Patients
- (2022) Michael Roderick Cook et al. Blood Advances
- Phase Ib/II Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab and Lenalidomide in Refractory/Recurrent Primary (PCNSL) and Secondary Central Nervous System Lymphoma (SCNSL)
- (2022) Christian Grommes et al. BLOOD
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- Efficacy and Safety of Axicabtagene Ciloleucel and Tisagenlecleucel Administration in Lymphoma Patients With Secondary CNS Involvement: A Systematic Review
- (2021) XiaoQin Wu et al. Frontiers in Immunology
- CAR T-cell Therapy for Secondary CNS DLBCL
- (2021) Gulrayz Ahmed et al. Blood Advances
- CD19 directed CAR T cell therapy for treatment of primary CNS lymphoma
- (2021) Tanya Siddiqi et al. Blood Advances
- Primary Central Nervous System Lymphoma
- (2021) Lauren R. Schaff et al. BLOOD
- Rituximab-Lenalidomide-Ibrutinib Combination for Relapsed/Refractory Primary CNS Lymphoma
- (2021) Caroline Houillier et al. NEUROLOGY
- Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma
- (2020) Yoshitaka Narita et al. NEURO-ONCOLOGY
- EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
- (2020) Maher K Gandhi et al. BLOOD
- Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)†
- (2019) H Ghesquieres et al. ANNALS OF ONCOLOGY
- Tisagenlecleucel CAR-T Cell Therapy in Secondary CNS Lymphoma
- (2019) Matthew J. Frigault et al. BLOOD
- Phase Ib of Copanlisib in Combination with Ibrutinib in Recurrent/Refractory Primary CNS Lymphoma (PCNSL)
- (2019) Christian Grommes et al. BLOOD
- Phase I study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreo-retinal lymphoma
- (2018) Han W. Tun et al. BLOOD
- Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma
- (2018) Prakash Ambady et al. LEUKEMIA & LYMPHOMA
- Phase Ib trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
- (2018) Christian Grommes et al. BLOOD
- The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades
- (2017) Joe S Mendez et al. NEURO-ONCOLOGY
- Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
- (2017) Christian Grommes et al. Cancer Discovery
- Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma
- (2016) Agnieszka Korfel et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
- (2008) G. Lenz et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now